日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Prognostic value of flow cytometry in myelodysplastic neoplasms (MDS): Composition of a FCM-prognostic score (FCM-PS) for overall survival

流式细胞术在骨髓增生异常综合征(MDS)预后中的价值:构建用于预测总生存期的FCM预后评分(FCM-PS)。

Santaolalla, Aida; Oelschlaegel, Uta; Winter, Susann; Jamshidi, Shirin; Westers, Theresia M; Sockel, Katja; Bornhäuser, Martin; Ejarque, Rosa Andres; Farzaneh, Farzin; Poloni, Antonella; Kubasch, Anne-Sophie; Van Hemelrijck, Mieke; van de Loosdrecht, Arjan A; Platzbecker, Uwe; Kordasti, Shahram

Venetoclax plus hypomethylating agents as a bridge to transplant or donor lymphocyte infusion in relapsed/ refractory acute myeloid leukemia

维奈托克联合去甲基化药物作为复发/难治性急性髓系白血病患者移植或供体淋巴细胞输注前的桥梁治疗

Verdeyen, Kathelijn; Reuvekamp, Tom; Van der Velden, Walter J F M; Wouters, Bas J; Von dem Borne, Peter A; Van Rhenen, Anna; Lissenberg-Witte, Birgit I; Van Lammeren, Daniëlle; Van Sluis, Geerte L; De Jongh, Eva; Fiets, Roel B; Corsten, Maarten F; Van der Spek, Arie C; Gerrits, Anke M; Van Bladel, Esther R; Tick, Lidwine W; De Weerdt, Okke; Van Zaane, Bregje; Cruijsen, Marjan J; Posthuma, Eduardus F M; Van Elssen, Catharina H M J; Klein, Saskia K; Van de Loosdrecht, Arjan A; De Leeuw, David C

An inflammatory T-cell-stromal axis contributes to hematopoietic stem/progenitor cell failure and clonal evolution in human myelodysplastic syndrome.

炎症性 T 细胞-基质轴导致人类骨髓增生异常综合征中造血干/祖细胞衰竭和克隆演变。

Chen Lanpeng, Bian Yujie, Pronk Eline, van Dijk Claire, V D van Tienhoven Tim, Hoogenboezem Remco M, Bindels Eric M, Bosch Dennis, Fazeli Sadaf, de Graaf Aniek O, Westers Theresia M, Kholmatov Maksim, Zaugg Judith B, Moura Pedro L, Hellström-Lindberg Eva, van de Loosdrecht Arjan A, Jansen Joop H, Sanders Mathijs A, Raaijmakers Marc H G P

Transcriptional profiling directs the classification of acute leukemias of ambiguous lineage into AML, B-ALL, or T-ALL

转录组分析指导将谱系不明的急性白血病分类为急性髓系白血病 (AML)、B细胞急性淋巴细胞白血病 (B-ALL) 或T细胞急性淋巴细胞白血病 (T-ALL)。

Mulet-Lazaro, Roger; Sijs-Szabó, Anikó; Hoogenboezem, Remco M; van Herk, Stanley; Exalto, Carla; Koenders, Jasper E; Hoogeveen, Patricia G; Kavelaars, François G; Schelen, Anita M; van den Ancker, Willemijn; van de Loosdrecht, Arjan A; Mullighan, Charles G; Beverloo, H Berna; van der Velden, Vincent; Cornelissen, Jan J; Valk, Peter J M; Rijneveld, Anita W; Sanders, Mathijs A

Applications of machine learning for immunophenotypic measurable residual disease assessment in acute myeloid leukemia

机器学习在急性髓系白血病免疫表型可测量残留病灶评估中的应用

Mocking, Tim R; van de Loosdrecht, Arjan A; Cloos, Jacqueline; Bachas, Costa

High levels of global hydroxymethylation predict worse overall survival in MDS patients treated with azacitidine

全球羟甲基化水平升高预示着接受阿扎胞苷治疗的MDS患者总体生存期较差。

Tiso, Francesca; In 't Hout, Florentien E M; Knops, Ruth; Kroeze, Leonie I; van Rooij, Arno; van de Loosdrecht, Arjan A; Westers, Theresia M; Langemeijer, Saskia M C; Preudhomme, Claude; Duployez, Nicolas; Fenaux, Pierre; Kosmider, Olivier; Bouscary, Didier; de Graaf, Aniek O; Martens, Joost H A; van der Reijden, Bert A; Adès, Lionel; Fontenay, Michaela; Jansen, Joop H

Validation of the diagnostic potential of 17 immunophenotypic core markers defined by the ELN-iMDS-Flow Working Group in an independent cohort of patients with MDS

在独立的MDS患者队列中验证ELN-iMDS-Flow工作组定义的17种免疫表型核心标志物的诊断潜力。

Veenstra, Coen R; Alhan, Canan; Westers, Theresia M; van de Loosdrecht, Arjan A

CD34+CD38- leukemia stem cells predict clinical outcomes in acute myeloid leukemia patients treated non-intensively with hypomethylating agents

CD34+CD38-白血病干细胞可预测接受非强化低甲基化药物治疗的急性髓系白血病患者的临床结局。

Reuvekamp, Tom; Ngai, Lok Lam; den Hartog, Daphne; Carbaat-Ham, Jannemieke; Fayed, Mona M H E; Scholten, Willemijn J; Mocking, Tim R; Chitu, Dana A; Pabst, Thomas; Klein, Saskia K; Stussi, Georg; Griskevicius, Laimonas; Breems, Dimitri; van Lammeren-Venema, Danielle; Boersma, Rinske; Ossenkoppele, Gert J; van de Loosdrecht, Arjan A; Bachas, Costa; Huls, Gerwin; de Leeuw, David C; Cloos, Jacqueline

Computational measurable residual disease assessment in acute myeloid leukemia: a retrospective validation in the HOVON-SAKK-132 trial

急性髓系白血病中可计算的残留病灶评估:HOVON-SAKK-132 试验的回顾性验证

Mocking, Tim R; Haaksma, Lukas H; Reuvekamp, Tom; Kelder, Angèle; Scholten, Willemijn J; Ngai, Lok Lam; Breems, Dimitri A; Fischer, Thomas; Gjertsen, Bjørn T; Griškevičius, Laimonas; Juliusson, Gunnar; Maertens, Johan A; Manz, Markus G; Pabst, Thomas; Passweg, Jakob R; Porkka, Kimmo; Valk, Peter J M; Gradowska, Patrycja; Löwenberg, Bob; de Leeuw, David C; Janssen, Jeroen J W M; Ossenkoppele, Gert J; van de Loosdrecht, Arjan A; Cloos, Jacqueline; Bachas, Costa

Diagnosis of myelodysplastic syndromes: the classic and the novel

骨髓增生异常综合征的诊断:经典方法与新方法

Oster, Howard S; Van de Loosdrecht, Arjan A; Mittelman, Moshe